Table 2 Robust Mendelian randomization analysis of association between ganglion cell inner plexiform layer thickness and Parkinson’s disease.

From: Mendelian randomization reveals association between retinal thickness and non-motor symptoms of Parkinson’s disease

 

RAPS

MR-Egger

WME

Weighted MBE

Outcome

Beta or OR (95%CI)

P

Beta or OR (95%CI)

P

Beta or OR (95%CI)

P

Beta or OR (95%CI)

P

Risk

1.006 (0.982,1.029)

0.641

1.029 (0.925,1.144)

0.606

1.014 (0.980,1.049)

0.436

1.016 (0.973,1.061)

0.482

Constipation

0.900 (0.771,1.051)

0.184

1.026 (0.727,1.446)

0.889

0.947 (0.773,1.159)

0.595

0.964 (0.742,1.253)

0.790

Daytime sleepiness

0.960 (0.823,1.120)

0.605

1.067 (0.754,1.510)

0.722

0.930 (0.751,1.150)

0.502

0.893 (0.653,1.220)

0.493

Dementia

1.076 (0.924,1.253)

0.348

0.991 (0.700,1.402)

0.960

1.061 (0.879,1.280)

0.537

1.039 (0.817,1.322)

0.759

Depression

1.104 (0.933,1.305)

0.249

1.185 (0.811,1.730)

0.403

1.059 (0.870,1.289)

0.569

1.056 (0.814,1.372)

0.689

Dyskinesias

1.089 (0.901,1.318)

0.377

1.059 (0.691,1.623)

0.800

0.988 (0.767,1.273)

0.929

0.946 (0.635,1.410)

0.794

HY3

1.059 (0.848,1.322)

0.613

1.056 (0.635,1.757)

0.838

1.120 (0.838,1.497)

0.445

1.138 (0.703,1.843)

0.611

Hyposmia

1.017 (0.881,1.174)

0.816

1.075 (0.774,1.493)

0.676

0.997 (0.825,1.204)

0.971

0.981 (0.745,1.292)

0.894

Insomnia

1.090 (0.963,1.234)

0.172

1.218 (1.027,1.445)

0.047

1.123 (0.959,1.315)

0.148

1.126 (0.910,1.393)

0.299

Motor fluctuation

0.982 (0.834,1.158)

0.832

1.244 (0.878,1.763)

0.266

0.962 (0.782,1.183)

0.713

0.936 (0.712,1.229)

0.648

RBD

1.199 (0.972,1.479)

0.091

1.461 (0.893,2.391)

0.166

1.328 (1.019,1.730)

0.036

1.354 (0.935,1.960)

0.140

AAO

−0.054 (−0.210,0.103)

0.503

−0.144 (−0.514,0.226)

0.455

−0.037 (−0.241,0.167)

0.722

−0.006 (−0.276,0.264)

0.968

UPDRS total

0.012 (−0.032,0.057)

0.592

−0.003 (−0.091,0.085)

0.951

0.038 (−0.021,0.097)

0.203

0.038 (−0.047,0.123)

0.397

UPDRS1

−0.011 (−0.064,0.041)

0.676

0.000 (−0.117,0.117)

0.999

0.001 (−0.065,0.067)

0.967

0.002 (−0.075,0.079)

0.963

UPDRS2

−0.023 (−0.076,0.031)

0.409

0.052 (−0.067,0.171)

0.415

−0.031 (−0.100,0.039)

0.391

−0.040 (−0.135,0.054)

0.427

UPDRS3

−0.022 (−0.068,0.024)

0.347

−0.068 (−0.170,0.035)

0.230

−0.015 (−0.076,0.045)

0.616

−0.011 (−0.096,0.073)

0.800

UPDRS4

−0.004 (−0.053,0.045)

0.865

0.025 (−0.037,0.087)

0.454

0.014 (−0.047,0.075)

0.654

0.019 (−0.047,0.084)

0.587

MMSE

0.009 (−0.082,0.101)

0.839

−0.019 (−0.185,0.147)

0.829

0.029 (−0.092,0.150)

0.641

0.042 (−0.097,0.182)

0.567

MoCA

−0.067 (−0.306,0.172)

0.581

0.060 (−0.452,0.572)

0.827

−0.209 (−0.509,0.092)

0.173

−0.242 (−0.689,0.205)

0.325

SEADL

−0.160 (−0.578,0.258)

0.453

0.028 (−0.728,0.783)

0.944

0.133 (−0.394,0.660)

0.622

0.151 (−0.551,0.854)

0.680

  1. Abbreviations: HY3 Hoehn-Yahr stage of 3 or more, RBD Rapid eye movement sleep behavior disorder, UPDRS Unified Parkinson’s Disease Rating Scale, MMSE Mini–Mental State Examination, MoCA Montreal Cognitive Assessment, SEADL Schwab and England Activities of Daily Living Scale.